Current Research into Cures for Type-1 Diabetes

Diamyd Fails in Phase-III Trial Diamyd's European phase-III trial has failed. The official quote is "did not meet the primary eff...

I'm a little embarrassed that it has taken me so long to blog about Dr. Orban's results.  They were announced almost a year ago. ...

Alefacept Starts a phase-II Clinical Trial This study is also called "T1DAL", which I'm sure is pronounced "tidal"....

This posting is a draft.  But I've been working on it for so long that I decided to publish what I have while continuing to refine it.  ...

Based on my last couple of posts, I got the two following questions: How is the phase-II Exsulin study that is currently underway, differe...

Exsulin's Phase-II Trial is Data Complete  The exact update I got on the Exsulin phase-II trial is this: "We have finished recrui...

Canakinumab Completes Enrollment Canakinumab is a monoclonal antibody, which is designed to lower inflammation.  It targets IL-1β (interl...